Skip to main content
. 2020 Nov 26;7:587012. doi: 10.3389/fmolb.2020.587012

FIGURE 3.

FIGURE 3

Design of nanoparticles for active uptake (Created with BioRender.com). (A) Monoclonal Antibodies, (B) Fabs, (C) Small Peptides, (D) Natural Proteins, (E) Aptamers, (F) Carbohydrates, (G) Small molecules.